AbbVie memproyeksikan EPS disesuaikan tahun 2026 sebesar $13,87-$14,07 seiring ekspektasi pendapatan ~$67,6 miliar dan EPS Q3 sebesar $3,84-$3,88 (NYSE:ABBV)
· seekingalpha.com
Wawasan laporan laba Q2 2026 AbbVie (ABBV): pertumbuhan Skyrizi/Rinvoq, katalis neurosains, dan dilusi kesepakatan Apogee.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...